Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
|
In millions, except per share items | Jul-30-23 | Apr-30-23 | Oct-30-22 | Jul-31-22 | May-01-22 | Jan-30-22 | Oct-31-21 | Aug-01-21 |
| 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
Revenues: |
United States | 1,039.0 | 1,113.0 | 830.0 | 725.0 | 702.0 | 847.0 | 673.0 | 533.0 |
Other | 5,386.0 | 5,517.0 | 5,919.0 | 5,795.0 | 5,543.0 | 5,424.0 | 5,450.0 | 5,663.0 |
Total revenues [+] | 6,425.0 | 6,630.0 | 6,749.0 | 6,520.0 | 6,245.0 | 6,271.0 | 6,123.0 | 6,196.0 |
Products | 6,425.0 | 6,630.0 | 6,749.0 | 6,520.0 | 6,245.0 | 6,271.0 | 6,123.0 | 6,196.0 |
Revenue growth [+] | -1.5% | 6.2% | 10.2% | 5.2% | 11.9% | 21.5% | 30.6% | 41.0% |
United States | 43.3% | 58.5% | 23.3% | 36.0% | 43.6% | 146.9% | 50.2% | 33.6% |
Cost of goods sold | 3,449.0 | 3,536.0 | 3,648.0 | 3,514.0 | 3,318.0 | 3,312.0 | 3,178.0 | 3,229.0 |
Gross profit | 2,976.0 | 3,094.0 | 3,101.0 | 3,006.0 | 2,927.0 | 2,959.0 | 2,945.0 | 2,967.0 |
Gross margin | 46.3% | 46.7% | 45.9% | 46.1% | 46.9% | 47.2% | 48.1% | 47.9% |
Selling, general and administrative [+] | 407.0 | 408.0 | 381.0 | 377.0 | 347.0 | 333.0 | 310.0 | 314.0 |
Sales and marketing | 193.0 | 194.0 | 183.0 | 180.0 | 173.0 | 167.0 | 155.0 | 159.0 |
General and administrative | 214.0 | 214.0 | 198.0 | 197.0 | 174.0 | 166.0 | 155.0 | 155.0 |
Other selling, general and administrative | | | | | | | | |
Research and development | 767.0 | 775.0 | 726.0 | 705.0 | 686.0 | 654.0 | 622.0 | 640.0 |
Equity in earnings | | | | | | | | |
EBITDA [+] | 1,938.0 | | 2,117.0 | 2,032.0 | 2,005.0 | 2,074.0 | 2,118.0 | 2,111.0 |
EBITDA growth | -4.6% | -4.7% | 0.0% | -3.7% | 19.2% | 35.6% | 53.5% | 75.6% |
EBITDA margin | 30.2% | 28.8% | 31.4% | 31.2% | 32.1% | 33.1% | 34.6% | 34.1% |
Depreciation | 125.0 | -12.0 | 113.0 | 97.0 | 102.0 | 92.0 | 93.0 | 87.0 |
EBITA | 1,813.0 | 1,923.0 | 2,004.0 | 1,935.0 | 1,903.0 | 1,982.0 | 2,025.0 | 2,024.0 |
EBITA margin | 28.2% | 29.0% | 29.7% | 29.7% | 30.5% | 31.6% | 33.1% | 32.7% |
Amortization of intangibles | 11.0 | 12.0 | 10.0 | 11.0 | 9.0 | 10.0 | 12.0 | 11.0 |
EBIT [+] | 1,802.0 | 1,911.0 | 1,994.0 | 1,924.0 | 1,894.0 | 1,972.0 | 2,013.0 | 2,013.0 |
EBIT growth | -6.3% | 0.9% | -0.9% | -4.4% | 19.5% | 37.4% | 56.9% | 81.7% |
EBIT margin | 28.0% | 28.8% | 29.5% | 29.5% | 30.3% | 31.4% | 32.9% | 32.5% |
Non-recurring items | | | | | | -4.0 | -1.0 | |
Interest expense | 60.0 | 61.0 | 57.0 | 56.0 | 58.0 | 57.0 | 57.0 | 57.0 |
Interest expense | 60.0 | 61.0 | 57.0 | 56.0 | 58.0 | 57.0 | 57.0 | 57.0 |
Other income (expense), net [+] | 64.0 | -73.0 | 12.0 | -7.0 | 28.0 | 6.0 | 49.0 | 24.0 |
Gain (loss) on derivative instruments | 24.0 | 12.0 | 14.0 | 20.0 | 7.0 | -8.0 | 15.0 | 9.0 |
Other | 64.0 | -73.0 | 12.0 | -7.0 | 28.0 | 6.0 | 49.0 | 24.0 |
Pre-tax income | 1,806.0 | 1,777.0 | 1,949.0 | 1,861.0 | 1,864.0 | 1,925.0 | 2,006.0 | 1,980.0 |
Income taxes | 246.0 | 202.0 | 358.0 | 255.0 | 328.0 | 133.0 | 294.0 | 264.0 |
Tax rate | 13.6% | 11.4% | 18.4% | 13.7% | 17.6% | 6.9% | 14.7% | 13.3% |
Net income | 1,560.0 | 1,575.0 | 1,591.0 | 1,606.0 | 1,536.0 | 1,792.0 | 1,712.0 | 1,716.0 |
Net margin | 24.3% | 23.8% | 23.6% | 24.6% | 24.6% | 28.6% | 28.0% | 27.7% |
|
Basic EPS [+] | $1.86 | $1.87 | $1.83 | $1.86 | $1.75 | $2.02 | $1.88 | $1.89 |
Growth | 0.1% | 6.8% | -2.9% | -1.6% | 20.8% | 63.2% | 52.4% | 105.6% |
Diluted EPS [+] | $1.85 | $1.86 | $1.81 | $1.85 | $1.74 | $2.00 | $1.86 | $1.87 |
Growth | 0.1% | 6.9% | -2.6% | -1.1% | 21.2% | 63.5% | 52.0% | 104.9% |
|
Dividends per share [+] | $0.32 | | $0.26 | $0.26 | $0.24 | $0.24 | $0.24 | $0.24 |
Growth | 22.8% | -100.0% | 7.9% | 8.0% | 9.2% | 9.6% | 8.7% | 9.3% |
|
Shares outstanding (basic) [+] | 838.0 | 843.0 | 871.0 | 864.0 | 878.0 | 889.0 | 910.0 | 908.0 |
Growth | -3.0% | -4.0% | -4.3% | -4.8% | -4.4% | -2.8% | -0.7% | -0.8% |
Shares outstanding (diluted) [+] | 843.0 | 847.0 | 877.0 | 869.0 | 883.0 | 897.0 | 919.0 | 918.0 |
Growth | -3.0% | -4.1% | -4.6% | -5.3% | -4.7% | -3.0% | -0.4% | -0.4% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|